Global Patent Index - EP 3498307 A1

EP 3498307 A1 20190619 - CONTRAST AGENTS, METHODS FOR PREPARING CONTRAST AGENTS, AND METHODS OF IMAGING

Title (en)

CONTRAST AGENTS, METHODS FOR PREPARING CONTRAST AGENTS, AND METHODS OF IMAGING

Title (de)

KONTRASTMITTEL, VERFAHREN ZUR HERSTELLUNG VON KONTRASTMITTELN UND ABBILDUNGSVERFAHREN

Title (fr)

AGENTS DE CONTRASTE, PROCÉDÉS DE PRÉPARATION D'AGENTS DE CONTRASTE ET PROCÉDÉS D'IMAGERIE

Publication

EP 3498307 A1 20190619 (EN)

Application

EP 18204561 A 20090402

Priority

  • US 4169308 P 20080402
  • EP 09755461 A 20090402
  • US 2009039276 W 20090402

Abstract (en)

Embodiments of the present disclosure provide for contrast agents, methods of making contrast agents, and methods of using contrast agents, and the like.

IPC 8 full level

A61K 49/14 (2006.01); A61K 49/12 (2006.01); A61P 35/00 (2006.01)

CPC (source: EP US)

A61K 49/126 (2013.01 - EP US); A61K 49/14 (2013.01 - EP US); A61K 49/143 (2013.01 - EP US); A61P 35/00 (2018.01 - EP)

Citation (applicant)

  • US 4816567 A 19890328 - CABILLY SHMUEL [US], et al
  • US 5831012 A 19981103 - NILSSON BJOERN [SE], et al
  • "Computational Molecular Biology", 1988, OXFORD UNIVERSITY PRESS
  • "Biocomputing: Informatics and Genome Projects", 1993, ACADEMIC PRESS
  • "Computer Analysis of Sequence Data", 1994, HUMANA PRESS
  • HEINJE, G.: "Sequence Analysis in Molecular Biology", 1987, ACADEMIC PRESS
  • "Sequence Analysis Primer", 1991, M STOCKTON PRESS
  • CARILLO, H.; LIPMAN, D.: "SIAM J Applied Math.", vol. 48, 1988, pages: 1073
  • NEEDELMAN; WUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 443 - 453
  • ROBERTSON ET AL., J. AM. CHEM. SOC., vol. 113, 1991, pages 2722
  • ELLMAN ET AL., METHODS ENZYMOL., vol. 202, 1991, pages 301
  • CHUNG ET AL., SCIENCE, vol. 259, 1993, pages 806 - 9
  • CHUNG ET AL., PROC. NATL. ACAD. SCI. USA, vol. 90, 1993, pages 10145 - 9
  • TURCATTI ET AL., J. BIOL. CHEM., vol. 271, 1996, pages 19991 - 8
  • KOIDE ET AL., BIOCHEM., vol. 33, 1994, pages 7470 - 6
  • WYNN ET AL., PROTEIN SCI, vol. 2, 1993, pages 395 - 403
  • HARLOW; LANE: "Antibodies: A Laboratory Manual", 1988, COLD SPRING HARBOR LABORATORIES
  • GODING: "Monoclonal Antibodies: Principles and Practice", 1986, ACADEMIC PRESS
  • "Remington's Pharmaceutical Sciences", 1990, MACK PUBLISHING
  • TYSZKA, J. M.; FRASER, S. E.; JACOBS, R. E., CURR OPIN BIOTECHNOL, vol. 16, no. 1, 2005, pages 93 - 99
  • LIPPARD, S. J., NAT CHERN BIOL, vol. 2, no. 10, 2006, pages 504 - 507
  • LOUIE, A. Y.; HUBER, M. M.; AHRENS, E. T.; ROTHBACHER, U.; MOATS, R.; JACOBS, R. E.; FRASER, S. E.; MEADE, T. J., NAT BIOTECHNOL, vol. 18, no. 3, 2000, pages 321 - 325
  • FRANGIONI, J. V., NAT BIOTECHNOL, vol. 24, no. 8, 2006, pages 909 - 913
  • WOODS, M.; WOESSNER, D. E.; SHERRY, A. D., CHERN SOC REV, vol. 35, no. 6, 2006, pages 500 - 511
  • LAUFFER, R. B., CHEM. REV., vol. 87, 1987, pages 901 - 927
  • AIME, S.; BARGE, A.; CABELLA, C.; CRICH, S. G.; GIANOLIO, E., CURR PHARM BIOTECHNOL, vol. 5, no. 6, 2004, pages 509 - 518
  • TOTH, E.; HELM, L.; MERBACH, A. E.: "Contrast Agents I: Magnetic Resonance Imaging", vol. 221, 2002, pages: 61 - 102
  • MERBACH, A. E.; TOTH, E., THE CHEMISTRY OF CONTRAST AGENT AGENTS IN MEDICAL MAGNETIC RESONANCE IMAGING, 2001
  • GERALDES, C. F.; SHERRY, A. D.; CACHERIS, W. P.; KUAN, K. T.; BROWN, R. D.; KOENIG, S. H.; SPILLER, M., MAGN RESON MED, vol. 8, no. 2, 1988, pages 191 - 199
  • CARAVAN, P., CHEM SOC REV, vol. 35, no. 6, 2006, pages 512 - 523
  • WEINMANN, H. J.; PRESS, W. R.; GRIES, H., INVEST RADIOL, vol. 25, no. 1, 1990, pages 49 - 50
  • OPSAHL, L. R.; UZGIRIS, E. E.; VERA, D. R., ACAD RADIOL, vol. 2, no. 9, 1995, pages 762 - 767
  • LANGEREIS, S.; DE LUSSANET, Q. G.; VAN GENDEREN, M. H.; MEIJER, E. W.; BEETS-TAN, R. G.; GRIFFIOEN, A. W.; VAN ENGELSHOVEN, J. M.;, NMR BIOMED, vol. 19, no. 1, 2006, pages 133 - 141
  • BRYANT, L. H., JR.; BRECHBIEL, M. W.; WU, C.; BULTE, J. W.; HERYNEK, V.; FRANK, J. A., JMAGN RESON IMAGING, vol. 9, no. 2, 1999, pages 348 - 352
  • SIRLIN, C. B.; VERA, D. R.; CORBEIL, J. A.; CABALLERO, M. B.; BUXTON, R. B.; MATTREY, R. F., ACAD RADIOL, vol. 11, no. 12, 2004, pages 1361 - 1369
  • LANZA, G. M.; WINTER, P.; CARUTHERS, S.; SCHMEIDER, A.; CROWDER, K.; MORAWSKI, A.; ZHANG, H.; SCOTT, M. J.; WICKLINE, S. A., CURR PHARM BIOTECHNOL, vol. 5, no. 6, 2004, pages 495 - 507
  • KARFELD, L. S.; BULL, S. R.; DAVIS, N. E.; MEADE, T. J.; BARRON, A. E., BIOCONJUG CHEM, vol. 18, no. 6, 2007, pages 1697 - 1700
  • GILLIES, R. J., J CELL BIOCHEM SUPPL, vol. 39, 2002, pages 231 - 238
  • ARTEMOV, D.; BHUJWALLA, Z. M.; BULTE, J. W., CURR PHARM BIOTECHNOL, vol. 5, no. 6, 2004, pages 485 - 494
  • AIME, S.; CABELLA, C.; COLOMBATTO, S.; GENINATTI CRICH, S.; GIANOLIO, E.; MAGGIONI, F., JMAGN RESON IMAGING, vol. 16, no. 4, 2002, pages 394 - 406
  • ANDERSON, E. A.; ISAACMAN, S.; PEABODY, D. S.; WANG, E. Y.; CANARY, J. W.; KIRSHENBAUM, K., NANO LETT, vol. 6, no. 6, 2006, pages 1160 - 1164
  • STRIJKERS, G. J.; MULDER, W. J.; VAN HEESWIJK, R. B.; FREDERIK, P. M.; BOMANS, P.; MAGUSIN, P. C.; NICOLAY, K., MAGMA, vol. 18, no. 4, 2005, pages 186 - 192
  • CARAVAN, P.; GREENWOOD, J. M.; WELCH, J. T.; FRANKLIN, S. J., CHEM COMMUN (CAMB, vol. 20, 2003, pages 2574 - 2575
  • KIM, Y.; WELCH, J. T.; LINDSTROM, K. M.; FRANKLIN, S. J., J BIOL INORG CHEM, vol. 6, no. 2, 2001, pages 173 - 181
  • SUDNICK, D. R.; HORROCKS, W. D., JR., BIOCHIM BIOPHYS ACTA, vol. 578, no. 1, 1979, pages 135 - 144
  • BEEBY, A.; CLARKSON, I. M.; DICKINS, R. S.; FAULKNER, S.; PARKER, D.; ROYLE, L.; DE SOUSA, A. S.; GARETH WILLIAMS, J. A.; WOODS, M, J. CHEM. SOC., PERKIN TRANS., vol. 2, 1999, pages 493 - 504
  • MARTELL, A. E.; SIMTH, R. M.; MOTEKAITIS, R. J., NIST STANDARD REFERENCE DATA, 1993
  • WILKINS, A. L.; YANG, W.; YANG, J. J., CURR PROTEIN PEPT SCI, vol. 4, no. 5, 2003, pages 367 - 373
  • YANG, W.; WILKINS, A. L.; LI, S.; YE, Y.; YANG, J. J., BIOCHEMISTRY, vol. 44, no. 23, 2005, pages 8267 - 8273
  • YANG, W.; WILKINS, A. L.; YE, Y.; LIU, Z. R.; LI, S. Y.; URBAUER, J. L.; HELLINGA, H. W.; KEARNEY, A.; VAN DER MERWE, P. A.; YANG,, JAM CHEM SOC, vol. 127, no. 7, 2005, pages 2085 - 2093
  • DENG, H.; CHEN, G.; YANG, W.; YANG, J. J., PROTEINS, vol. 64, no. 1, 2006, pages 34 - 42
  • YANG, W.; LEE, H. W.; HELLINGA, H.; YANG, J. J., PROTEINS, vol. 47, no. 3, 2002, pages 344 - 356
  • PIDCOCK, E.; MOORE, G. R., J BIOL INORG CHEM, vol. 6, no. 5-6, 2001, pages 479 - 489
  • YANG, W.; JONES, L. M.; ISLEY, L.; YE, Y.; LEE, H. W.; WILKINS, A.; LIU, Z. R.; HELLINGA, H. W.; MALCHOW, R.; GHAZI, M., JAM CHEM SOC, vol. 125, no. 20, 2003, pages 6165 - 6171
  • MANICCIA, A. W.; YANG, W.; LI, S. Y.; JOHNSON, J. A.; YANG, J. J., BIOCHEMISTRY, vol. 45, no. 18, 2006, pages 5848 - 5856
  • YE, Y.; LEE, H. W.; YANG, W.; SHEALY, S. J.; WILKINS, A. L.; LIU, Z. R.; TORSHIN, I.; HARRISON, R.; WOHLHUETER, R.; YANG, J. J., PROTEIN ENG, vol. 14, no. 12, 2001, pages 1001 - 1013
  • YE, Y.; LEE, H. W.; YANG, W.; SHEALY, S.; YANG, J. J., JAM CHEM SOC, vol. 127, no. 11, 2005, pages 3743 - 3750
  • WEDEKING, P.; SHUKLA, R.; KOUCH, Y. T.; NUNN, A. D.; TWEEDLE, M. F., MAGN RESON IMAGING, vol. 17, no. 4, 1999, pages 569 - 575
  • KUMAR K.; TWEEDLE, M. F.; MALLEY, M. F.; COUGOUTAS, J. Z., INORG. CHEM., vol. 34, 1995, pages 6472 - 6480
  • CACHERIS, W. P.; QUAY, S. C.; ROCKLAGE, S. M., MAGN RESON IMAGING, vol. 8, no. 4, 1990, pages 467 - 481
  • BULTE, J. W.; KRAITCHMAN, D. L., NMR BIOMED, vol. 17, no. 7, 2004, pages 484 - 499
  • WYSS, D. F.; DAYIE, K. T.; WAGNER, G., PROTEIN SCI, vol. 6, no. 3, 1997, pages 534 - 542
  • RAO, S. T.; SATYSHUR, K. A.; GREASER, M. L.; SUNDARALINGAM, M., ACTA CRYSTALLOGR D BIOL CRYSTALLOGR, vol. 52, 1996, pages 916 - 922
  • BARNHART, J. L.; KUHNERT, N.; BAKAN, D. A.; BERK, R. N., MAGN RESON IMAGING, vol. 5, no. 3, 1987, pages 221 - 231
  • VAN ZIJL, P. C.; JONES, C. K.; REN, J.; MALLOY, C. R.; SHERRY, A. D., PROC NATL ACADSCI USA, vol. 104, no. 11, 2007, pages 4359 - 4364
  • LAUFFER, R. B.; PARMELEE, D. J.; OUELLET, H. S.; DOLAN, R. P.; SAJIKI, H.; SCOTT, D. M.; BERNARD, P. J.; BUCHANAN, E. M.; ONG, K., ACAD RADIOL, vol. 3, no. 2, 1996, pages 356 - 358
  • LAUFFER, R. B.; PARMELEE, D. J.; DUNHAM, S. U.; OUELLET, H. S.; DOLAN, R. P.; WITTE, S.; MCMURRY, T. J.; WALOVITCH, R. C., RADIOLOGY, vol. 207, no. 2, 1998, pages 529 - 538
  • PARMELEE, D. J.; WALOVITCH, R. C.; OUELLET, H. S.; LAUFFER, R. B., INVEST RADIOL, vol. 32, no. 12, 1997, pages 741 - 747
  • ALLEN, M. J.; MEADE, T. J., J BIOL INORG CHEM, vol. 8, no. 7, 2003, pages 746 - 750
  • BRASCH, R.; TURETSCHEK, K., EUR JRADIOL, vol. 34, no. 3, 2000, pages 148 - 155
  • YANG ET AL., BIOCHEM, 2006
  • YANG ET AL., JACS, 2008
  • LEE ET AL., BBA, 2003
  • YANG, JACS, 2008
  • GABERC-POREKAR V; ZORE I; PODOBNIK B; MENART V: "Obstacles and pitfalls in the PEGylation of therapeutic proteins", CURR OPIN DRUG DISCOV DEVEL., vol. 11, no. 2, March 2008 (2008-03-01), pages 242 - 50
  • FISHBURN CS: "The pharmacology of PEGylation: Balancing PD with PK to generate novel therapeutics", J PHARM SCI, 15 January 2008 (2008-01-15)
  • VERONESE FM; PASUT G: "PEGylation, successful approach to drug delivery", DRUG DISCOV TODAY, vol. 10, no. 21, 1 November 2005 (2005-11-01), pages 1451 - 8, XP005124583, DOI: doi:10.1016/S1359-6446(05)03575-0
  • HARRIS JM; CHESS RB: "Effect of pegylation on pharmaceuticals", NAT REV DRUG DISCOV., vol. 2, no. 3, March 2003 (2003-03-01), pages 214 - 21, XP009042217, DOI: doi:10.1038/nrd1033
  • YANG, W.; WILKINS, A. L.; LI, S.; YE, Y.; YANG, J. J.: "The effects of Ca2+ binding on the dynamic properties of a designed Ca2+-binding protein", BIOCHEMISTRY, vol. 44, 2005, pages 8267 - 73, XP055102376, DOI: doi:10.1021/bi050463n
  • ADAIR, F.; OZANNE, D.: "The immunogenicity of therapeutic proteins", BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, vol. 15, 2002, pages 30
  • LEYLAND-JONES, B.; ARNOLD, A.; GELMON, K.; VERMA, S.; AYOUB, J. P.; SEIDMAN, A.; DIAS, R.; HOWELL, J.; RAKHIT, A.: "Pharmacologic insights into the future of trastuzumab", ANN ONCOL, vol. 12, no. 1, 2001, pages 43 - 7
  • HERMELING, S.; CROMMELIN, D. J.; SCHELLEKENS, H.; JISKOOT, W.: "Structure-immunogenicity relationships of therapeutic proteins", PHARM RES, vol. 21, 2004, pages 897 - 903, XP002407776, DOI: doi:10.1023/B:PHAM.0000029275.41323.a6
  • LUCAS, A.; MCFADDEN, G.: "Secreted immunomodulatory viral proteins as novel biotherapeutics", J IMMUNOL, vol. 173, 2004, pages 4765 - 74, XP002447030
  • SCHELLEKENS, H.: "Immunogenicity of therapeutic proteins: clinical implications and future prospects", CLIN THER, vol. 24, 2002, pages 1720 - 40, XP002465634, DOI: doi:10.1016/S0149-2918(02)80075-3
  • SCHELLEKENS, H.: "Bioequivalence and the immunogenicity of biopharmaceuticals", NAT REV DRUG DISCOV, vol. 1, 2002, pages 457 - 62, XP008041096, DOI: doi:10.1038/nrd818
  • FEDERICO, R.; CONA, A.; CALICETI, P.; VERONESE, F. M.: "Histaminase PEGylation: Preparation and characterization of a new bioconjugate for therapeutic application", J CONTROL RELEASE, vol. 115, 2006, pages 168 - 174, XP024957654, DOI: doi:10.1016/j.jconrel.2006.07.020
  • VERONESE, F. M.; PASUT, G.: "PEGylation, successful approach to drug delivery", DRUG DISCOV TODAY, vol. 10, 2005, pages 1451 - 8, XP005124583, DOI: doi:10.1016/S1359-6446(05)03575-0
  • BHADRA, D.; BHADRA, S.; JAIN, P.; JAIN, N. K.: "Pegnology: a review of PEG-ylated systems", PHARMAZIE, vol. 57, 2002, pages 5 - 29, XP001115789
  • BAILON, P.; PALLERONI, A.; SCHAFFER, C. A.; SPENCE, C. L.; FUNG, W. J.; PORTER, J. E.; EHRLICH, G. K.; PAN, W.; XU, Z. X.; MODI, M: "Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis C", BIOCONJUG CHEM, vol. 12, 2001, pages 195 - 202, XP002264676, DOI: doi:10.1021/bc000082g
  • BASU, A.; YANG, K.; WANG, M.; LIU, S.; CHINTALA, R.; PALM, T.; ZHAO, H.; PENG, P.; WU, D.; ZHANG, Z.: "Structure-function engineering of interferon-beta-lb for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation", BIOCONJUG CHEM, vol. 17, 2006, pages 618 - 30
  • KOZLOWSKI, A.; CHARLES, S. A.; HARRIS, J. M.: "Development of pegylated interferons for the treatment of chronic hepatitis C", BIODRUGS, vol. 15, 2001, pages 419 - 29, XP002903517, DOI: doi:10.2165/00063030-200115070-00001
  • KOZLOWSKI, A.; HARRIS, J. M.: "Improvements in protein PEGylation: pegylated interferons for treatment of hepatitis C", J CONTROL RELEASE, vol. 72, 2001, pages 217 - 24, XP004246451, DOI: doi:10.1016/S0168-3659(01)00277-2
  • YANG, Z.; WANG, J.; LU, Q.; XU, J.; KOBAYASHI, Y.; TAKAKURA, T.; TAKIMOTO, A.; YOSHIOKA, T.; LIAN, C.; CHEN, C.: "PEGylation confers greatly extended half- life and attenuated immunogenicity to recombinant methioninase in primates", CANCER RES, vol. 64, 2004, pages 6673 - 8, XP003025733, DOI: doi:10.1158/0008-5472.CAN-04-1822
  • NIE, Y.; ZHANG, X.; WANG, X.; CHEN, J.: "Preparation and stability of N-terminal mono-PEGylated recombinant human endostatin", BIOCONJUG CHEM, vol. 17, 2006, pages 995 - 9, XP002593170, DOI: doi:10.1021/BC050355D
  • DAUGHERTY, A. L.; MRSNY, R. J.: "Formulation and delivery issues for monoclonal antibody therapeutics", ADV DRUG DELIV REV, vol. 58, 2006, pages 686 - 706, XP024892149, DOI: doi:10.1016/j.addr.2006.03.011
  • MOHS, A. M.; ZONG, Y.; GUO, J.; PARKER, D. L.; LU, Z. R.: "PEG-g-poly(GdDTPA-co-L-cystine): effect of PEG chain length on in vivo contrast enhancement in MRI", BIOMACROMOLECULES, vol. 6, 2005, pages 2305 - 11
  • LUCIANI, A.; OLIVIER, J. C.; CLEMENT, O.; SIAUVE, N.; BRILLET, P. Y.; BESSOUD, B.; GAZEAU, F.; UCHEGBU, I. F.; KAHN, E.; FRIJA, G.: "Glucose-receptor MR imaging of tumors: study in mice with PEGylated paramagnetic niosomes", RADIOLOGY, vol. 231, 2004
  • YANG JJ; YANG J; WEI L; ZURKIYA O; YANG W; LI S; ZOU J; ZHOU Y; MANICCIA AL; MAO H: "Rational design of protein-based MRI contrast agents", J AM CHEM SOC, vol. 130, no. 29, 2008, pages 9260 - 7, XP002627489, DOI: doi:10.1021/ja800736h

Citation (search report)

  • [XY] WO 2007009058 A2 20070118 - UNIV GEORGIA STATE RES FOUND [US], et al
  • [XY] WO 2007030802 A2 20070315 - UNIV GEORGIA STATE RES FOUND [US], et al
  • [XY] WO 2005016387 A2 20050224 - UNIV IOWA RES FOUND [US], et al
  • [XY] CARAVAN P ET AL: "GADOLINIUM-BINDING HELIX-TURN-HELIX PEPTIDES: DNA-DEPENDENT MRI CONTRAST AGENTS", CHEMICAL COMMUNICATIONS, ROYAL SOCIETY OF CHEMISTRY, no. 20, 21 October 2003 (2003-10-21), XP008041846, ISSN: 1359-7345, DOI: 10.1039/B307817E
  • [Y] YIMING YE ET AL: "Metal binding affinity and structural properties of an isolated EF-loop in a scaffold protein", PROTEIN ENGINEERING, DESIGN AND SELECTION, vol. 14, no. 12, 1 December 2001 (2001-12-01), GB, pages 1001 - 1013, XP055497800, ISSN: 1741-0126, DOI: 10.1093/protein/14.12.1001
  • [Y] ROBERTS M J ET AL: "Chemistry for peptide and protein PEGylation", ADVANCED DRUG DELIVERY REVIEWS, ELSEVIER, AMSTERDAM, NL, vol. 54, no. 4, 17 June 2002 (2002-06-17), pages 459 - 476, XP002293146, ISSN: 0169-409X, DOI: 10.1016/S0169-409X(02)00022-4
  • [Y] VERONESE F M ET AL: "PEGylation, successful approach to drug delivery", DRUG DISCOVERY TODAY, ELSEVIER, RAHWAY, NJ, US, vol. 10, no. 21, 1 November 2005 (2005-11-01), pages 1451 - 1458, XP027684962, ISSN: 1359-6446, [retrieved on 20051101]
  • [Y] BOGDANOV A A ET AL: "LONG-CIRULCATING BLOOD POOL IMAGING AGENTS", ADVANCED DRUG DELIVERY REVIEWS, ELSEVIER, AMSTERDAM, NL, vol. 16, no. 2/03, 1 January 1995 (1995-01-01), pages 335 - 348, XP002037424, ISSN: 0169-409X, DOI: 10.1016/0169-409X(95)00034-5
  • [Y] STRIJKERS G J ET AL: "Relaxivity of liposomal paramagnetic MRI contrast agents", MAGNETIC RESONANCE MATERIALS IN PHYSICS, BIOLOGY AND MEDICINE, CHAPMAN AND HALL, LONDON, GB, vol. 18, no. 4, 1 September 2005 (2005-09-01), pages 186 - 192, XP019358213, ISSN: 1352-8661
  • [Y] DAN M. J. DOBLE ET AL: "Optimization of the Relaxivity of MRI Contrast Agents: Effect of Poly(ethylene glycol) Chains on the Water-Exchange Rates of Gd III Complexes", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 123, no. 43, 1 October 2001 (2001-10-01), pages 10758 - 10759, XP055139116, ISSN: 0002-7863, DOI: 10.1021/ja011085m
  • [Y] AARON M. MOHS ET AL: "-cystine): Effect of PEG Chain Length on in Vivo Contrast Enhancement in MRI", BIOMACROMOLECULES, vol. 6, no. 4, 1 July 2005 (2005-07-01), pages 2305 - 2311, XP055139119, ISSN: 1525-7797, DOI: 10.1021/bm050194g
  • [Y] SHI KE ET AL: "Imaging taxane-induced tumor apoptosis using PEGylated, 111In-labeled annexin V.", THE JOURNAL OF NUCLEAR MEDICINE, vol. 45, no. 1, 1 January 2004 (2004-01-01), pages 108 - 15, XP055139123, ISSN: 0161-5505

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

DOCDB simple family (publication)

WO 2009146099 A2 20091203; WO 2009146099 A3 20100218; EP 2257316 A2 20101208; EP 2257316 A4 20141022; EP 2257316 B1 20181107; EP 3498307 A1 20190619; US 10849993 B2 20201201; US 11738098 B2 20230829; US 2011097742 A1 20110428; US 2018250426 A1 20180906; US 2021038745 A1 20210211; US 2024082434 A1 20240314

DOCDB simple family (application)

US 2009039276 W 20090402; EP 09755461 A 20090402; EP 18204561 A 20090402; US 201815910893 A 20180302; US 202017068215 A 20201012; US 202318346503 A 20230703; US 93541309 A 20090402